CompagOs AG
Early detection of bone metastases in cancer patients.
CompagOs develops Bon3OID™-Dx, a blood-based functional diagnostic for early detection of bone metastases in lung, breast, and prostate cancer patients. Instead of waiting for lesions to appear on CT, PET-CT, or MRI, the test measures how a patient’s blood cells affect a living, 3D bioprinted human bone model, enabling detection of destructive bone activity 6–12 months earlier than imaging. Bon3OID™-Dx supports earlier intervention, repeat monitoring, and better treatment decisions. The platform is built on more than 10 years of ETH Zürich research. The serviceable available market is about USD 12B.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
29.06.2023
CompagOs wins CHF 150,000 to advance personalized medicine for bone cancer (venturekick.ch)
15.03.2026
Successful completion of first clinical pilot
20.02.2026
Achieved Go/No-Go Milestone for Innosuisse Project
17.12.2024
31.05.2023
Finalized incorporation team
04.05.2023
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
CompagOs AG
Early detection of bone metastases in cancer patients.
Website:
www.compagos.ch
Headquarter:
Hünenberg
Foundation Date:
September 2023
Technology:
- Medtech
Sectors:
- 3D Printing
- Applications
- Biomaterials
- Biotech
- Consulting services
- Hightech
- Materials
- Instruments
- Drug development platforms
- Interdisciplinary
- Drug discovery
- Mechanics
- Imaging and Radiology
- Medtech
- Research and development
- Services for companies
- Organ and Tissues
- Orthopedics
- Screening
Support received
